Attovia Therapeutics Inc. (ATTO)
NASDAQ: ATTOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 16.42 0.00%
ATTO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $749.59M
- EPS (TTM)
- -$2.74
- Dividend yield
- None
- 52-week range
- 16.15 – 28.00
- Day range
- 16.33 – 17.54
- Volume / Avg
- 515.67K / 456.94K
- Beta
- —
- Shares outstanding
- 45.65M
- Next earnings
- Nov 11, 2026
52-week range
ATTO stock today
Shares of Attovia Therapeutics (ATTO) finished lower on Oct 7 at $16.42, a drop of 6.17% or $1.08 per share, versus the S&P 500's 0.22% decline. At this level, ATTO sits near the bottom of its 52-week range of $16.15 to $28.00: 41.4% below the high, set on Sep 8, 2026 and 1.7% above the low. Attovia Therapeutics has posted a net loss over the last twelve months (EPS of -$2.74), so its P/E ratio is not meaningful.
Attovia Therapeutics's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Attovia Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2026
Earnings
Earnings history- Next report
- Nov 11, 2026
Attovia Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs ATTO |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.47 | -7.57% | $772.39M | vs ATTO |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs ATTO |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs ATTO |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs ATTO |
| GLUEMonte Rosa Therapeutics Inc. | 10.17 | +3.04% | $867.64M | vs ATTO |
| ODTXOdyssey Therapeutics Inc. | 18.08 | -0.28% | $868.90M | vs ATTO |
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs ATTO |
Indexes, lists and sector
Attovia Therapeutics stock FAQ
What is Attovia Therapeutics's stock price today?
ATTO last traded at $16.42 as of Oct 7, 4:00 PM EDT, down 6.17% on the day. Prices are delayed at least 15 minutes.
When is Attovia Therapeutics's next earnings date?
Attovia Therapeutics is expected to report earnings on Wednesday, November 11, 2026.
What is the ATTO 52-week high?
The 52-week high for ATTO is $28.00 and the 52-week low is $16.15. The stock is currently 41.4% below its high.